Meet the GC Aesthetics Team

Here at GC Aesthetics, we believe that our success lies in the skills of our people.

CEO Ayse Kocak is supported by a committed team across a broad range of disciplines.

Together they aspire to make GC Aesthetics the leading independent medical aesthetic company in the world - not only delighting physicians with high quality products but also supporting and educating women in making an informed choice.

Ayse Kocak – Chief Executive Officer

Ayse Kocak has served as our Chief Executive Officer since February 2013 and has been a member of the Board since February 2012. Prior to joining the Company as Chief Executive Officer, from February 2009 to February 2013, Ms. Kocak started and served as a general manager at moksha8 Pharmaceuticals, Inc. in Mexico, a specialty pharmaceutical company that focuses on therapeutics to treat the central nervous system and mental health disorders. Previously, Ms. Kocak served in various commercial roles with subsidiaries of Pfizer Inc. around the world, including in the United States, Europe, Latin America, Africa and the Middle East, and was involved in the launch and commercialization of Lipitor®, Viagra®, Norvasc® and Geodon®. Ms. Kocak holds a bachelor’s degree from Bosphorous University.

Barry Hatt – Chief Technical Operations Officer

Barry Hatt has served as our Chief Technical Operations Officer since April 2015. Previously, from May 2011 to March 2015 and May 2008 to May 2011, Mr. Hatt served as our Chief Operating Officer and Vice President of Manufacturing and Operations, respectively. Previously, Mr. Hatt has held various management positions in both pharmaceutical and medical devices sectors with Bristol-Myers Squibb Company, Warner- Lambert Co. and Inamed Corp. At Inamed, he ran the international breast implant manufacturing operations. Mr. Hatt holds a Ph.D. in microbiology and a bachelor’s degree from University College, Dublin.

Carlos Reis Pinto – Chief Operations Officer

Carlos Reis Pinto joined GCA in December 2016. During the last 20 years, he has gained significant experience in driving organisational efficiency and profitability in highly regulated environments and across different positions. Prior to joining GCA, Carlos spent six years as the COO of Novescia and Cerba Healthcare, both owned by two successive private equities partners in the blood laboratory testing industry. He also spent 11 years at GE Healthcare in various roles across their vascular and mammography products such as Innova, Seno Essential® or Seno Bright®. Carlos holds a bachelor’s degree from Paris XI University.

Ignasi Salla – Chief Sales and Marketing Officer

Ignasi Salla leads our sales and marketing function and previously served as our Vice President Sales EMEA until March 2017. From March 2011 to January 2015, Mr. Salla was our Country Manager for Spain. Prior to joining the Company, from November 2005 to March 2011, Mr. Salla served as a sales manager for Mediform Group, an aesthetics distributor in Spain. Mr. Salla has also worked with Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson. Mr. Salla holds a bachelor’s degree from Escuela de Administración de Empresas, Barcelona.

Julia Marsan – Chief Human Resources Officer

Julia Marsan has served as our Chief Human Resources Officer since December 2013. Prior to joining the Company, from 2006 to 2012, Ms. Marsan was the human resources director for DX Network Services, an independent mail, parcels and logistics end-to-end network operator in the United Kingdom and Ireland and has also worked with Thames Water Utilities Limited. Ms. Marsan holds a bachelor’s degree from the University of Leeds.

Michael Bogle – Chief Financial Officer

Michael Bogle has served as our Chief Financial Officer since September 2016, prior to this he served as our Group Financial Director having joined GC Aesthetics in December 2010. He has over 20 years international finance and commercial experience, 16 years at senior management level, gained in the leisure, IT and venture capital industries. Mr. Bogle is a member of the Institute of Chartered Accountants of Scotland and holds an MA Joint Honours in Economics and Accountancy from Aberdeen University. 

Vikash Agarwal – Chief Corporate Development & Strategy Officer

Vikash Agarwal has served as our Chief Corporate Development & Strategy Officer since June 2015. Previously from August 2014 to June 2015, Mr. Agarwal served as our Vice President of Corporate Business Development & Strategic Planning. Prior to joining the Company, from January 2013 to August 2014, Mr. Agarwal served as head of mergers and acquisitions for Sun Pharmaceuticals Industries Ltd., a global specialty pharmaceutical company. Previously, Mr. Agarwal was an independent advisor in the health care industry from December 2011 to December 2012 and held various positions in the investment banking department of HSBC Bank plc from April 2006 to November 2011. Mr. Agarwal holds a master's in business administration from INSEAD and a bachelor's degree from Delhi University.